Biotech Advisors Aps Nordic serves as Executive at Osteologix, Inc., where they oversee executive responsibilities. Since joining the company, Biotech Advisors Aps Nordic has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Apr 17, 2008 involved purchasing 3,030,304 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Apr 17, 2008 | OLGX.OB | $0 | Purchase | 3,030,304 | $N/A | Discretionary |
Biotech Advisors Aps Nordic currently holds 18,163,365 shares of Osteologix, Inc. (OLGX.OB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Biotech Advisors Aps Nordic has been a net neutral trader of OLGX.OB stock. They have purchased $0 and sold $0 worth of shares.
Biotech Advisors Aps Nordic's most recent insider trade was on Apr 17, 2008, when they purchased 3,030,304 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted